HRT Financial’s Global Blood Therapeutics, Inc. GBT Stock Holding History

HRT Financial’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-213,168	Closed	-$14.5M	–	3839
2022 Q3	$14.5M	Buy	+213,168	New	+$11.8M	0.16%	95
2021 Q4	–	Sell	-45,632	Closed	-$1.16M	–	4403
2021 Q3	$1.16M	Buy	+45,632	New	+$1.34M	0.01%	1133
2020 Q3	–	Sell	-44,442	Closed	-$2.81M	–	2513
2020 Q2	$2.81M	Buy	+44,442	New	+$3.05M	0.08%	256
2019 Q4	–	Sell	-5,510	Closed	-$267K	–	1806
2019 Q3	$267K	Buy	+5,510	New	+$287K	0.01%	1004

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

HRT Financial's GBT Position: Q4 2022 in Review

HRT Financial sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 213,168 shares — an estimated $14.5M sold.

HRT Financial first reported a position in GBT in Q3 2019 and held it in 4 quarters. The position peaked at $14.5M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

HRT Financial reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
HRT Financial sold 213,168 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $14.5M.
HRT Financial first reported a position in Global Blood Therapeutics, Inc. in Q3 2019 and held it in 4 quarters.
HRT Financial's Global Blood Therapeutics, Inc. position peaked at $14.5M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on HRT Financial's 13F filing for Q4 2022, filed 10 Feb 2023.